9.73
+0.68
+(7.51%)
At close: April 9 at 4:00:03 PM EDT
9.92
+0.19
+(1.95%)
After hours: April 9 at 4:25:02 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 10 | 10 |
Avg. Estimate | 0.11 | 0.1 | 0.45 | 0.53 |
Low Estimate | 0.1 | 0.09 | 0.41 | 0.44 |
High Estimate | 0.12 | 0.12 | 0.49 | 0.6 |
Year Ago EPS | 0.1 | 0.07 | 0.45 | 0.45 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 10 | 10 |
Avg. Estimate | 104.47M | 103.59M | 419.46M | 453.51M |
Low Estimate | 102.3M | 101.33M | 405.06M | 425.22M |
High Estimate | 107.1M | 104.9M | 424.3M | 463.4M |
Year Ago Sales | 96.65M | 93.31M | 385.15M | 419.46M |
Sales Growth (year/est) | 8.09% | 11.01% | 8.91% | 8.12% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 0.1 | 0.1 | 0.11 | 0.13 |
EPS Actual | 0.1 | 0.07 | 0.13 | 0.15 |
Difference | 0 | -0.03 | 0.02 | 0.02 |
Surprise % | 0.81% | -32.08% | 17.64% | 19.63% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.11 | 0.1 | 0.45 | 0.53 |
7 Days Ago | 0.11 | 0.11 | 0.46 | 0.53 |
30 Days Ago | 0.11 | 0.11 | 0.46 | 0.53 |
60 Days Ago | 0.12 | 0.12 | 0.5 | 0.57 |
90 Days Ago | 0.12 | 0.12 | 0.5 | 0.57 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | -- | -- |
Up Last 30 Days | 1 | -- | -- | -- |
Down Last 7 Days | 2 | 4 | 1 | 3 |
Down Last 30 Days | 2 | 4 | 8 | 3 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CERT | 8.44% | 47.81% | 0.24% | 16.51% |
S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
Maintains | Barclays: Equal-Weight to Equal-Weight | 2/28/2025 |
Reiterates | Stephens & Co.: Overweight to Overweight | 2/27/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 11/7/2024 |
Maintains | Baird: Neutral to Neutral | 11/5/2024 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 10/15/2024 |
Upgrade | UBS: Neutral to Buy | 9/27/2024 |
Related Tickers
HSTM HealthStream, Inc.
31.79
+2.88%
SLP Simulations Plus, Inc.
25.55
+5.36%
ACCD Accolade, Inc.
7.02
0.00%
HQY HealthEquity, Inc.
83.13
+8.28%
PRVA Privia Health Group, Inc.
23.05
+6.03%
SDGR Schrödinger, Inc.
19.52
+8.63%
EVH Evolent Health, Inc.
10.00
+4.71%
TALK Talkspace, Inc.
2.9200
+7.35%
PINC Premier, Inc.
19.68
+3.91%
WAY Waystar Holding Corp.
37.52
+6.35%